CD274 and neoplasm of esophagus: In addition, our data suggested that patients with positive PD-L1 expression, of Asian regions, with esophageal tumors, and scheduled for second-line treatment; male patients; and patients ≥65 years of age could benefit from ICIs, instead of chemotherapy.